Maxibiotic

Bacitracin Zinc, Neomycin Sulfate and Polymyxin B Sulfate, the active ingredients in Maxibiotic, are a topical antibiotic combination presented as a topical formulation for external use. They treat bacterial skin infections, minor wounds and superficial burns in adults and children.

GNH USA supplies Maxibiotic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxibiotic is a topical antibacterial preparation used for skin conditions caused by susceptible bacteria.

Impetigo: reduces bacterial load and promotes healing of superficial infection caused by Staphylococcus aureus or Streptococcus pyogenes. Minor cuts and abrasions: prevents infection and supports tissue repair on small traumatic lesions. Superficial burns: provides antibacterial protection to aid recovery of first‑degree burns. Post‑surgical wound care: helps prevent bacterial colonisation of minor incision sites.

Topical application of Maxibiotic may cause local reactions, although most are mild and self‑limiting.

Common Side Effects: - Local irritation or burning sensation at the application site. - Redness or mild erythema. - Itching or pruritus. - Dryness or peeling of the skin. - Minor rash or papular eruption.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or vesiculation. - Anaphylactic reaction presenting with systemic urticaria, airway compromise. - Nephrotoxicity or ototoxicity if absorbed in large amounts, especially with extensive use. - Severe skin necrosis or ulceration. - Systemic hypersensitivity reactions such as fever or malaise.

Before using Maxibiotic, consider the following safety measures.

Allergy assessment: avoid if known hypersensitivity to any component. Pregnancy and lactation: use only when the benefit outweighs potential risk. Age considerations: apply with caution in infants and the elderly. Application area: limit to small, intact skin surfaces; avoid eyes, ears, mucous membranes. Concurrent skin conditions: do not use on eczematous, ulcerated or compromised skin. Store at room temperature: keep in the original container, protect from moisture and heat.

Topical and systemic agents may influence the safety or efficacy of Maxibiotic.

Major Interactions (Avoid): - Systemic aminoglycosides: increased risk of nephrotoxicity and ototoxicity. - Concurrent topical antibiotics: heightened local irritation and allergic potential.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antibacterial effectiveness. - Antifungal agents: possible antagonistic effect on bacterial coverage. - Silver‑containing dressings: may interact with polymyxin B activity.